Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
14.27
-0.02 (-0.14%)
At close: Feb 3, 2026

SHE:002275 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,0802,1922,1681,9541,7391,564
Other Revenue
1.761.763.665.272.712.79
2,0822,1942,1721,9601,7411,566
Revenue Growth (YoY)
-1.56%1.03%10.81%12.55%11.15%-4.51%
Cost of Revenue
576.55610.47602.57574.37457.04449.25
Gross Profit
1,5051,5841,5691,3851,2841,117
Selling, General & Admin
825.1888.26920.66812.68722.13628.74
Research & Development
149.5173.29158.06217.04201.6147.56
Other Operating Expenses
61.9632.2829.8936.0932.830.4
Operating Expenses
1,0501,1031,1091,070957.81803.92
Operating Income
454.88480.47460.41315.65326.37313.31
Interest Expense
-8.79-13.84-16.36-20.24-18.21-11.55
Interest & Investment Income
44.534.433.1740.6439.829.41
Currency Exchange Gain (Loss)
0.190.19-0.08-3.590.570.01
Other Non Operating Income (Expenses)
-8.08-0.250.05-0.58-1.23-0.14
EBT Excluding Unusual Items
482.7500.97477.2331.89347.31331.05
Gain (Loss) on Sale of Investments
8.44.651.190.161.77-1.37
Gain (Loss) on Sale of Assets
79.2383.361.6731.2615.5-
Asset Writedown
2.21-0.86-0.17-1.02-8.12-1.71
Other Unusual Items
75.9655.8238.3983.8972.6116.2
Pretax Income
648.49643.93518.28446.18429.06344.17
Income Tax Expense
125.61122.496.99116.6585.3467.14
Net Income
522.88521.53421.3329.53343.72277.02
Net Income to Common
522.88521.53421.3329.53343.72277.02
Net Income Growth
28.07%23.79%27.85%-4.13%24.08%-29.36%
Shares Outstanding (Basic)
581586585588573577
Shares Outstanding (Diluted)
581586585588573577
Shares Change (YoY)
-1.61%0.15%-0.56%2.72%-0.74%-1.39%
EPS (Basic)
0.900.890.720.560.600.48
EPS (Diluted)
0.900.890.720.560.600.48
EPS Growth
30.16%23.61%28.57%-6.67%25.00%-28.36%
Free Cash Flow
579.5506.16472.85466.4266.15392.52
Free Cash Flow Per Share
1.000.860.810.790.470.68
Dividend Per Share
0.5500.6000.6000.8000.9000.400
Dividend Growth
---25.00%-11.11%125.00%73.91%
Gross Margin
72.30%72.17%72.25%70.69%73.75%71.32%
Operating Margin
21.85%21.90%21.20%16.11%18.74%20.00%
Profit Margin
25.12%23.77%19.40%16.81%19.74%17.68%
Free Cash Flow Margin
27.84%23.07%21.77%23.80%15.29%25.06%
EBITDA
527.7571.42575.53412.21412.97393.58
EBITDA Margin
25.35%26.05%26.50%21.03%23.72%25.12%
D&A For EBITDA
72.8390.95115.1296.5586.680.27
EBIT
454.88480.47460.41315.65326.37313.31
EBIT Margin
21.85%21.90%21.20%16.11%18.74%20.00%
Effective Tax Rate
19.37%19.01%18.71%26.15%19.89%19.51%
Revenue as Reported
2,0822,1942,1721,9601,7411,566
Advertising Expenses
-530.36514.72361.86378.9364.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.